U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07365566) titled 'Pain Assessment in Patients With Idiopathic REM Sleep Behaviour Disorder' on Jan. 16.
Brief Summary: Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease, with over 12 million patients expected globally by 2040. The disease is currently diagnosed at the appearance of motor symptoms, but by then, over 60% of striatal dopaminergic neurons have already been destroyed. Prodromal symptoms such as idiopathic REM Sleep Behavior Disorder (iRBD), anosmia, mood disorders and constipation appear earlier and are listed as criteria for a prodromal PD diagnosis. Identifying early signs is critica...